Before choosing a Science & Co plan, ask for two things together: the exact medication being proposed and the exact amount due when you enroll. The platform advertises several injectable and oral options, while its lowest published compounded-drug prices depend on 12-month plans. Those details matter more than a headline monthly figure. A useful comparison starts with a written offer connecting the product, prescribing service, dispensing pharmacy, payment schedule and cancellation rules—not with an assumption that every option follows the same arrangement.
This documentary review examines Science & Co’s public pages consulted October 19, 2026. The company advertises access to GLP-1 treatment, but its terms identify Science and Co, Inc., a Delaware corporation, as an administrative and technology platform rather than the medical provider or dispensing pharmacy. That distinction shapes the questions below: who evaluates you, who supplies the medicine, who answers problems and which organization controls a charge or replacement? The documentation answers parts of that sequence, but not every patient-facing detail.
At a glance
- Who provides care
- Science & Co says independent clinicians and professional entities provide medical services, while independent pharmacies dispense prescriptions; the platform itself does neither.Sources: [9]
- Published compounded-injection prices
- Compounded semaglutide injection starts at $59 per month and compounded tirzepatide injection at $99 per month on 12-month plans. The initial collection amount is not established.
- Consultation and prescribing
- The provider describes an approximately five-minute online intake and says most clinical reviews take 24–48 hours. A consultation and clinician approval are required before a prescription.
- Cancellation deadline
- Pause or cancel at least 72 hours before the next scheduled processing date, through the account or support email. Cancellation does not reverse an already prescribed, dispensed or shipped order.
Start with the medicine, not the plan name
Science & Co’s catalog spans distinct products. It advertises compounded semaglutide injection and compounded tirzepatide injection, plus branded Zepbound tirzepatide injection and Wegovy semaglutide injection. Its oral listings include Wegovy semaglutide tablets and Foundayo orforglipron tablets. These are the provider’s advertised offerings, not confirmation that every applicant can obtain every product. Before comparing plans, request the exact medication name, formulation, route and presentation that would appear on your prescription and pharmacy label.
A separate “Personalized GLP-1 & GIP-1” injectable page does not identify a specific active ingredient in the consulted description. Its starting price therefore does not establish that it is interchangeable with either named compounded injection. The Microdose offering also needs clarification: although catalog labeling includes “In Stock,” its dedicated page says “Coming Soon.” Treat availability as unconfirmed. The catalog additionally lists NAD+ and sermorelin injections under longevity; those listings do not explain the contents of a GLP-1 plan.
For the oral branded listings, Science & Co says Novo Nordisk manufactures Wegovy tablets and Eli Lilly manufactures Foundayo, with sealed, unaltered dispensing by a licensed US pharmacy. It also claims FDA approval for those products; those claims were not independently verified here. Generic pharmacy-manufacturing language elsewhere does not establish who manufactures a particular branded shipment. Our guide to identifying the medicine before comparing an offer provides a practical framework for getting that distinction in writing.
| Advertised option | Documented detail | Question to resolve |
|---|---|---|
| Compounded semaglutide injection | Starts at $59/month on a 12-month plan | What presentation and initial charge apply? |
| Compounded tirzepatide injection | Starts at $99/month on a 12-month plan | Which pharmacy would dispense it? |
| Personalized GLP-1 & GIP-1 injection | Starts at $59/month on a 12-month plan | What are the active ingredient and full composition? |
| Branded injections and tablets | Named products listed; prices not established | What is the product-specific cash price? |
| GLP-1/GIP-1 Microdose injection | Dedicated page says “Coming Soon” | Is enrollment actually available? |
Ask what will actually be charged today
The clearest published prices are starting figures for 12-month plans: $59 per month for compounded semaglutide injection and $99 per month for compounded tirzepatide injection. Both pages advertise the same price across doses, no monthly membership fee and free shipping. The personalized injectable also starts at $59 per month on a 12-month plan. None of those statements settles the amount collected initially, whether payment is monthly or upfront, or how an early cancellation affects the advertised plan price.
The semaglutide page displays a $149 reference figure and an advertised 60% saving; tirzepatide displays $199 and an advertised 50% saving. Separately, the homepage promotes 20% off the first month and a free online provider evaluation. The consulted documentation does not explain whether those promotions combine with the 12-month offers. Ask for the final checkout terms rather than assuming the reference figures are renewal charges or that another discount will automatically apply.
Subscription terms authorize automatic charges at intervals disclosed during checkout. They also say the total can include pharmacy charges, professional-service charges and platform-access fees. That is compatible with a bundled price, but it does not clarify every possible extra: requested laboratory work, for example, is not clearly addressed. No specific branded-product prices were established. Use these questions beyond the monthly price to request an itemized first charge, subsequent billing interval and treatment-specific list of inclusions before authorizing payment.
Identify the clinician and the consultation you are buying
Science & Co’s terms say services are available to people located in the United States, across all 50 states and the District of Columbia. Users must be at least 18. Those access conditions are not a complete treatment-eligibility policy. The consulted pages do not establish full clinical inclusion and exclusion criteria, systematic laboratory requirements or provider-specific BMI thresholds. Geographic availability also does not identify the professional entity or individual clinician who would take responsibility for your consultation.
The advertised process starts with an online questionnaire that takes about five minutes and initially carries no commitment. Example intake screens ask about previous GLP-1 use, type 2 diabetes, thyroid history, and pregnancy or nursing. These questions show topics being screened; they do not establish that every listed answer automatically disqualifies an applicant. The provider says most reviews finish within 24–48 hours. That is a clinical-review estimate, not a prescription guarantee or a delivery estimate.
The terms require a completed consultation, a determination that the product is appropriate and an issued prescription before a prescription product can be received. Science & Co further says each prescription comes from a clinician licensed in the patient’s state. Ask for that clinician’s name, US professional credential, practice entity and consultation format. The public documentation supports clinician review, but does not independently verify licensing or establish that every consultation includes a live video visit with a physician.
Clarify who follows your treatment between orders
The advertised plan includes an online assessment reviewed by a licensed clinician, a treatment plan, adjustments when clinically appropriate, secure messaging, scheduled check-ins, supplies, shipping and ongoing clinical monitoring. The FAQ says the same clinician stays with the patient month to month. That is a meaningful continuity claim, but the documentation does not name the clinician or explain coverage during absences. Ask whether messages reach that prescriber directly or first enter a general care-team queue.
Follow-up frequency is less settled than the broad inclusion list suggests. The homepage references monthly check-ins, while an illustrative interface describes weekly check-ins during the first eight weeks. Neither establishes one clear contractual schedule for every plan. Request the actual schedule for your proposed treatment, what each check-in involves and whether additional appointments carry charges. Monitoring should be described as a service with responsibilities, not simply as a statement that someone remains available while orders renew.
Science & Co advertises 24/7 support and says patients can message the care team anytime, but does not give a guaranteed response time. Its contact page calls account messaging the fastest route for existing members. It also publishes support@science.co and 1 (844) 587-5747. The site explicitly excludes medical emergencies and directs people to 911 or an emergency department. Our follow-up support questions can help separate routine messaging, clinician access and urgent-care boundaries.
Separate pharmacy claims from product evidence
For compounded treatment, Science & Co says it works only with state-licensed US compounding pharmacies, uses third-party purity and potency testing for every batch, and makes a Certificate of Analysis available on request. These are provider claims, not independently verified findings in this review. The consulted pages do not name the pharmacy that would fill an individual prescription. Ask for its identity, contact details, the proposed formulation and the documentation corresponding to your particular prescription.
Science & Co acknowledges that compounded drug products are not FDA approved or evaluated by FDA for safety, effectiveness or quality. FDA’s guidance adds an important patient-selection principle: compounded drugs should be used when an individual’s medical needs cannot be met by an FDA-approved drug, with a prescription and a state-licensed pharmacy. Ask the clinician to explain that rationale for the proposed preparation. Neither a testing claim nor a personalized label substitutes for that discussion.
Nonapproval alone does not prove clinical inequivalence, and it is not a provider-specific safety verdict. Conversely, approval of a particular branded product does not approve Science & Co or its compounded offerings. The company’s terms also disclose that some advertising imagery and before-and-after comparisons may be illustrative or computer- or AI-enhanced. Such material should not be treated as verified clinical outcomes. This review does not establish patient results for Science & Co or validate an individual product shipment.
Trace the prescription through delivery
The terms allow a patient to use a pharmacy accessible through the platform or ask for the prescription to be sent to a pharmacy of their choice. That choice deserves a specific billing conversation. The documentation does not establish whether outside fulfillment preserves the advertised bundle, free shipping or starting price. Before transferring a prescription, ask which organization will charge for the medicine and which clinical or platform charges, if any, remain payable to the service.
Science & Co advertises free home delivery and says medication arrives on a monthly schedule. It does not establish carrier details, preparation time, transit time, cold-chain procedures or a complete response process for lost or damaged packages. The advertised 24–48-hour review window should not be repurposed as an arrival promise. Request the dispensing pharmacy’s shipping instructions and an order-specific estimate, including who handles a delay after prescribing but before the package reaches you.
For injectable GLP-1 deliveries that arrive warm or insufficiently refrigerated, FDA explicitly advises not using the product and contacting the provider or dispensing pharmacy. The public documentation does not establish Science & Co’s replacement or refund rules for that situation. Its terms also warn that pharmacy products may lack child-resistant packaging or containers. Those are concrete questions to settle in advance: what packaging is supplied, who evaluates a delivery problem and what written resolution policy applies?
Resolve reimbursement before treating cash pay as temporary
The FAQ describes Science & Co as cash pay and says it does not submit claims to insurance, Medicare or Medicaid for patients. Its terms go further: neither the patient nor the participating platform, clinicians, professional entities or pharmacies may seek or receive reimbursement from federal, state or private healthcare payors for products or services obtained through the platform. Do not assume you can pay now and later submit the same purchase to your health plan.
That restriction is distinct from a statement that a particular insurance policy does not cover a medicine. The relevant question here is whether the proposed transaction fits the platform’s payment terms at all. Request clarification before enrollment if reimbursement is central to your budget. The provider also advertises “no insurance required,” but that does not establish a discount entitlement, a government-program benefit or a promise that the listed cash amount applies to every branded medication.
Science & Co says treatment is generally HSA- and FSA-eligible and offers itemized receipts. “Generally” should not be read as an individual tax or account-eligibility determination. Ask what the receipt itemizes and confirm requirements with your account administrator. Keep that inquiry separate from insurance reimbursement: an available receipt does not override the service’s payor restrictions. For budgeting, the useful document is a treatment-specific written quote, not a general statement that the platform accepts cash payment.
Get an exit answer before the first renewal
Science & Co says there is no lock-in or cancellation fee and permits pausing or canceling through the account. Its FAQ also allows email requests to support@science.co. The operational deadline is at least 72 hours before the next scheduled processing date—not necessarily 72 hours before delivery or before a date you infer from a prior payment. Ask where that processing date appears and how the company confirms that a pause or cancellation has taken effect.
The policy says cancellation stops future orders but does not reverse an order already prescribed, dispensed or shipped. Those are separate stages, so an order may be beyond the stated reversal boundary before it leaves a pharmacy. Cancellation is not a promise of a refund. The Shipping & Returns policy was not reviewed, and the consulted documentation does not establish a full refund, return or replacement policy, including the outcome if treatment is not prescribed.
A further question remains unresolved: how do the 12-month starting prices coexist with the advertised absence of lock-in? The pages do not explain whether early cancellation changes past pricing, future charges or any outstanding balance. Do not infer either mandatory annual prepayment or a penalty-free monthly financial arrangement. Use our questions before the next charge to request the initial payment, renewal schedule, cancellation consequences and refund boundaries together, preferably in a form you can retain.
Questions & answers
Is Science & Co itself my medical provider?
No. Its terms describe a technology platform connecting patients with independent clinicians. Professional entities provide healthcare, and pharmacies dispense prescriptions. Ask which professional entity and clinician would handle your care, and which pharmacy would fill the prescription. Those patient-specific identities were not established in the consulted documentation.
Can I enroll for compounded semaglutide at $59 without a longer plan?
The documented $59-per-month starting offer is specifically for compounded semaglutide injection on a 12-month plan. It is not a confirmed standalone monthly offer. The pages do not establish the first collection amount or the financial effect of leaving early, despite advertising no lock-in. Request those terms before paying.
Does the online questionnaire guarantee a prescription?
No. The terms require a consultation, a clinician’s determination that the product is appropriate and an issued prescription. Science & Co says most reviews take 24–48 hours, but that estimate does not guarantee approval, shipment or arrival. The sample intake questions are not a complete published eligibility policy.
Can I choose a different pharmacy?
The terms permit requesting that an issued prescription be sent to a pharmacy of your choice. They do not explain whether outside fulfillment preserves bundled pricing, supplies or free shipping. Confirm the receiving pharmacy’s ability to fill the exact prescription and obtain a revised breakdown of platform, clinical and medication charges.
Does 24/7 support mean a clinician responds immediately?
No guaranteed response time is published. Science & Co says patients may message the care team anytime and identifies account messaging as the fastest member contact route. That does not establish immediate clinician availability. The contact page explicitly says the site is not for medical emergencies and directs people to 911 or an emergency department.
If I cancel on time, will my last payment be refunded?
A refund is not established by the cancellation language. The documented rule requires at least 72 hours’ notice before scheduled processing and says cancellation does not reverse an already prescribed, dispensed or shipped order. A complete refund policy was not established in this review. Ask for the rule covering your specific order stage.
Our assessment
Science & Co documents a broad medication catalog, online clinician review, included messaging and monitoring, pharmacy choice and concrete cancellation contact paths. Those details give prospective patients more to work with than a price-only advertisement. Its principal gaps are practical: the actual initial payment on a 12-month offer, consequences of early cancellation, patient-specific clinician and pharmacy identities, branded-product prices and complete refund or delivery-problem policies. The next useful step is not to assume those gaps have favorable or unfavorable answers. Request one written, product-specific explanation linking the prescription, responsible organizations, first charge, recurring charges, follow-up schedule and exit terms. Clear answers would make comparison substantially easier; the public documentation alone does not settle them.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- Science & Co — contact ↗
- Science & Co — official website ↗
- Science & Co — weight loss/zepbound ↗
- Science & Co — weight loss/glp 1 gip 1 microdose ↗
- Science & Co — faq ↗
- Science & Co — weight loss/wegovy ↗
- Science & Co — weight loss/oral wegovy ↗
- Science & Co — terms conditions ↗
- Science & Co — weight loss/foundayo ↗
- Science & Co — weight loss/semaglutide ↗
- Science & Co — weight loss/tirzepatide ↗
- Science & Co — weight loss/compounded glp 1 gip 1 ↗